Mirae Asset Global Investments
VERV

Mirae Asset Global Investments’s Verve Therapeutics VERV Stock Holding History

Mirae Asset Global Investments’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,444
Closed -$38.7K – 1701
2025
Q2 		$38.7K Buy
3,444
+473
+16% +$2.7K ﹤0.01% 1298
2025
Q1 		$15.5K Buy
2,971
+150
+5% +$1K ﹤0.01% 1416
2024
Q4 		$17K Sell
2,821
-240
-8% -$1.35K ﹤0.01% 1442
2024
Q3 		$15.2K Buy
3,061
+554
+22% +$3.22K ﹤0.01% 1467
2024
Q2 		$11.9K Sell
2,507
-169,288
-99% -$1.06M ﹤0.01% 1444
2024
Q1 		$2.45M Buy
171,795
+59,034
+52% +$783K 0.01% 1099
2023
Q4 		$1.57M Sell
112,761
-99,343
-47% -$1.23M ﹤0.01% 1376
2023
Q3 		$2.81M Buy
212,104
+17,277
+9% +$278K 0.01% 1050
2023
Q2 		$3.65M Buy
194,827
+25,881
+15% +$431K 0.01% 982
2023
Q1 		$2.44M Buy
168,946
+12,165
+8% +$238K 0.01% 1116
2022
Q4 		$3.03M Buy
156,781
+19,982
+15% +$529K 0.01% 973
2022
Q3 		$4.7M Buy
136,799
+19,101
+16% +$610K 0.01% 822
2022
Q2 		$1.8M Buy
+117,698
New +$1.82M ﹤0.01% 1173

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mirae Asset Global Investments's VERV Position: Q3 2025 in Review

Mirae Asset Global Investments sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 3,444 shares — an estimated $38.7K sold.

Mirae Asset Global Investments first reported a position in VERV in Q2 2022 and held it in 13 quarters. The position peaked at $4.7M in Q3 2022. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Mirae Asset Global Investments reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 3,444 Verve Therapeutics shares in Q3 2025, an estimated $38.7K.
  • Mirae Asset Global Investments first reported a position in Verve Therapeutics in Q2 2022 and held it in 13 quarters.
  • Mirae Asset Global Investments's Verve Therapeutics position peaked at $4.7M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.